Opaleye Management Inc. Kal Vista Pharmaceuticals, Inc. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$7.58 - $12.25 $2.65 Million - $4.29 Million	-350,000 Reduced 70.0%	150,000 $1.84 Million
Q3 2023 Nov 14, 2023	SELL	$8.95 - $11.35 $1.97 Million - $2.5 Million	-220,000 Reduced 30.56%	500,000 $4.82 Million
Q2 2023 Aug 14, 2023	SELL	$7.73 - $10.57 $1.57 Million - $2.15 Million	-203,200 Reduced 22.01%	720,000 $6.48 Million
Q4 2022 Feb 10, 2023	BUY	$4.2 - $14.24 $3.88 Million - $13.1 Million	923,200 New	923,200 $6.24 Million
Q1 2021 May 18, 2021	SELL	$14.69 - $42.57 $6.91 Million - $20 Million	-470,203 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.83 - $13.99 $85,550 - $121,754	8,703 Added 1.89%	470,203 $5.86 Million
Q2 2020 Aug 14, 2020	BUY	$6.75 - $12.89 $1.6 Million - $3.05 Million	236,500 Added 105.11%	461,500 $5.58 Million
Q1 2020 May 15, 2020	BUY	$5.8 - $18.56 $1.31 Million - $4.18 Million	225,000 New	225,000 $1.72 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.